ADHD Clinical Trials
Attention Deficit Hyperactivity Disorder
Not Specified (Typically Phase 2-3)Active
Key Facts
Indication
Attention Deficit Hyperactivity Disorder
Phase
Not Specified (Typically Phase 2-3)
Status
Active
Company
About Boston Clinical Trials
Boston Clinical Trials is a private, revenue-generating clinical research organization (CRO) and site management organization (SMO) based in Roslindale, Massachusetts. Founded in 2008, it has conducted over 300 studies across more than 10 therapeutic areas, primarily focusing on central nervous system disorders, migraines, and other medical specialties. The company's business model is service-based, generating revenue from pharmaceutical and biotech sponsors for patient recruitment, trial execution, and site management. It differentiates itself through patient-centric services like compensation, evening appointments, and a convenient location.
View full company profileTherapeutic Areas
Other Attention Deficit Hyperactivity Disorder Drugs
| Drug | Company | Phase |
|---|---|---|
| ADHD Biomarker Program | Linus Biotechnology | Pre-clinical |
| ADHD Stimulant APIs | Noramco | Commercial |
| ADHD Drug (unspecified) | Granules India | ANDA Tentative Approval |